Compared with active drugs, oral semaglutide was superior to empagliflozin in reducing total cholesterol and LDL [36] and was superior to sitagliptin in reducing total cholesterol, LDL, and TAGs [37, 41], but there was no significant difference when compared with another GLP-1 analogue (liraglutide) [38]
Bands were developed using Clarity Western ECL substrate (Bio-Rad Laboratories, Hercules, CA, USA)
Increasing Prevalence of Type 2 Diabetes The cases of type 2 diabetes are rising across the world
For those who require maximal weight loss, such as people managing severe obesity alongside cardiovascular risk or obstructive sleep apnoea, injectable therapy may remain the medically preferred route
Individuals interested in GLP-1 receptor agonists should consult a doctor to determine if these medications are a suitable option
Up your fermented foods Your gut microbiome plays a starring role in GLP-1 production